Previous Close | €24.60 |
AI Value | €815.34 |
Upside potential | +3,214% |
MeVis Medical Solutions AG is a German-based provider of software solutions for digital imaging in medicine. The company specializes in advanced visualization and analysis tools for radiology, mammography, and other diagnostic imaging applications. MeVis operates primarily in Europe and North America, serving hospitals, research institutions, and healthcare providers. Its core products include MeVis BreastCare, a software suite for mammography, and MeVis Distant Services, which offers teleradiology solutions. The company's competitive advantage lies in its specialized expertise in medical imaging software, regulatory certifications (e.g., FDA and CE marks), and long-standing relationships with healthcare providers.
Holds patents in medical imaging algorithms; ongoing R&D in AI-assisted diagnostics (limited public updates on pipeline).
MeVis offers niche exposure to medical imaging software with stable revenue streams, but its small size and competition pose risks. Investment appeal hinges on successful AI product launches and healthcare IT adoption. Limited liquidity may deter large investors.
Company annual reports, German regulatory filings, industry reports (e.g., Statista).
Historical valuation data is not available at this time.